Abstract
A stability indicating RP-HPLC method for cephalexin has been developed and validated to identify and characterize potential degradation products. Drug was subjected to hydrolytic (acidic, basic, and neutral), oxidative, thermal, and photolytic stresses as per ICH guidelines Q1A (R2) and Q1B. Chromatographic separation was achieved on C8 column with mixture of ammonium acetate buffer pH 4.5 and acetonitrile in gradient mode as a mobile phase with PDA detection. Specificity of the method was established by peak purity studies. Method was validated as per ICH guideline Q2 (R1) for accuracy, precision, linearity, sensitivity, and robustness. Kinetics for each degradation condition was studied with respect to order of reaction and rate constant. Method was found to comply with acceptance criteria of validation parameters with respect to specificity (peak purity greater than 0.999) linearity (r 2 greater than 0.99), accuracy (% recovery in the range of 98–102%), and precision (% RSD not more than 2). A total of six degradation products were generated in different stress conditions; these were identified and structures were proposed using LC–MS/MS. Cephalexin undergoes degradation in almost all the conditions. The developed stability indicating method is suitable for analysis of stability samples as it adequately separates all degradation products. Degradation products generated in photolytic and oxidative conditions are reported for the first time.
Similar content being viewed by others
Abbreviations
- BP:
-
British Pharmacopoeia
- CPL:
-
Cephalexin
- ICH:
-
International conference of harmonization
- IP:
-
Indian Pharmacopoeia
- LC–MS:
-
Liquid chromatography–mass spectrometry
- PDA:
-
Photodiode array
- RP-HPLC:
-
Reversed-phase high-performance liquid chromatography
- RSD:
-
Relative standard deviation
- SIAM:
-
Stability indicating analytical method
- TOF:
-
Time of flight
- USP:
-
United States Pharmacopoeia
- UV:
-
Ultraviolet
References
Mishra L (2004) Drug today. Lorina Publications, Delhi
Eldin AB, Ismaiel OA, Hassan W, Shalaby A (2015) Development and validation of stability indicating green HPLC-UV method for determination of cephalexin in pharmaceutical dosage forms and human Urine using micellar mobile phase. Int J Pharm Pharm Sci 7:122–127
Hussein RF, Hammami MM (2014) Determination of cephalexin level and stability in human plasma by fully validated rapid HPLC analysis. World J Pharm Pharm Sci 3:20–31
Panda SS, Bera VV, Kumar R, Dash R, Mohanta G (2013) Determination of cephalexin monohydrate in pharmaceutical dosage form by stability-indicating RP-UFLC and UV spectroscopic methods. Sci Pharm 8:1029–1041
Fulias A, Vlase G, Vlase T, Soica C, Heghes A, Craina M, Ledeti I (2013) Comparative kinetic analysis on thermal degradation of some cephalosporins using TG and DSC data. Chem Cent J 7:1–8
Chen Y, Huang L, Lin Q (2012) Rapid hydrolysis and electrochemical detection of cephalexin at a heated glassy carbon electrode. Int J Electrochem Sci 7:7948–7959
Ofokansi KC, Uzor PF, Nnaji AM (2012) Kinetics of degradation and stability studies of cephalexin suspensions marketed in Nigeria. Afr J Pharm Res Dev 4:25–30
Guo W, Wang H, Shi Y and Zhang G (2016) Sonochemical degradation of the antibiotic cephalexin in aqueous solution. http://www.ajol.info/index.php/wsa/article/view/61998. Accessed on 01 Jan 2016
Reddy PRM, Sreeramulu J, Naidu PY, Reddy AR (2010) Stability indicating fast LC method for the estimation of impurities in cephalexin for oral suspension. Asian J Res Chem 3:1090–1094
Jeswani RM, Sinha PK, Topagi KS, Damle MC (2009) A validated stability indicating HPTLC method for determination of cephalexin in bulk and pharmaceutical formulation. Int J PharmTech Res 1:527–536
Dinner A (1977) Cephalosporin degradations. J Med Chem 20:963–965
International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (2003) ICH harmonized tripartite guideli, Topic Q1A (R2), Geneva, Switzerland
International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (1996) ICH harmonized tripartite guideline, Topic Q1B, Geneva, Switzerland
International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (2005) ICH harmonized tripartite guideline, Topic Q2(R1), Geneva, Switzerland
Acknowledgements
Authors are thankful to Sinhgad College of Pharmacy Vadgaon, (Bk.) Pune and Sophisticated Analytical Instrument Facility, IIT, Bombay for providing necessary facilities to carry out the work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interests regarding the publication of this paper.
Ethical approval
This article does not contain any studies with human participants/animals performed by any of the authors.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Gawande, V.T., Bothara, K.G. & Marathe, A.M. Stress Studies and Identification of Degradation Products of Cephalexin Using LC–PDA and LC–MS/MS. Chromatographia 80, 1545–1552 (2017). https://doi.org/10.1007/s10337-017-3385-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10337-017-3385-0